Gene · 8838
CCN6: cellular communication network factor 6
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCN6: cellular communication network factor 6. Genes, record 8838. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8838
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95389 | Cellular communication network factor 6 | 354 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents66
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 69932 | O95389 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 69935 | O95389 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 772 | O95389 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 547 | O95389 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14270 | O95389 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14271 | O95389 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14272 | O95389 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 8077 | O95389 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 8077 | O95389 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 547 | O95389 | Espacenet |
1 to 10 of 66
See all 66 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants669
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCN6 papers | Newest fiscal year |
|---|---|---|---|
| R01CA107469 | Role of EZH2 in Breast Cancer Progression | 20 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 15 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| ZIAAI001065 | India International Center for Excellence in Research | 3 | 2025 |
| P30AI045008 | Penn Center for AIDS Research | 2 | 2025 |
| P30AI050409 | Center for AIDS Research at Emory University | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 2 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 2 | 2025 |
1 to 10 of 669Source NIH's project files
See all 669 nih grantsPapers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Severe Phenotype in an Indian Family With Progressive Pseudorheumatoid Arthropathy of Childhood. | Am J Med Genet A | 2026 | 42728239 | PubTator, text mining | PubMed |
| WISP-3 promotes PDGF-B-mediated angiogenesis through suppression of let-7b-5p in rheumatoid arthritis. | Front Immunol | 2026 | 42591462 | PubTator, text mining | PubMed |
| Transcriptomic comparison of the infrapatellar fat pad between young patients with traumatic knee injury and older patients with knee osteoarthritis. | Connect Tissue Res | 2026 | 42560660 | PubTator, text mining | PubMed |
| WISP-3 promotes tumor-monocyte adhesion through a MEK/ERK-dependent miR-12131/ICAM-4 axis in lung adenocarcinoma. | Int J Med Sci | 2026 | 42524377 | PubTator, text mining | PubMed |
| Cardiorespiratory fitness, adiposity, and metabolic risk in breast cancer survivors: links with circulating WISP-1 and WISP-3. | Korean J Physiol Pharmacol | 2026 | 42481430 | PubTator, text mining | PubMed |
| WISP-3 drives LUAD metastasis by suppressing miR-5004-5p to upregulate MMP-12. | Biochem Pharmacol | 2026 | 42349620 | PubTator, text mining | PubMed |
| Species-specific roles of cellular communication network proteins in cartilage development: A comparative study using in vitro chondrogenic models. | J Cell Commun Signal | 2026 | 42256527 | PubTator, text mining | PubMed |
| Analysis of the current status and influencing factors of latent tuberculosis infection among new students in Taishan District in 2025. | Front Public Health | 2026 | 42232943 | PubTator, text mining | PubMed |
| The Role of the Cellular Communication Network Protein Family in Pulmonary Arterial Hypertension. | Pulm Circ | 2026 | 42146788 | PubTator, text mining | PubMed |
| WISP-3 promotes angiogenesis in non-small cell lung cancer through p38/JNK-c-Jun-mediated PDGF-A upregulation. | J Cancer | 2026 | 42038025 | PubTator, text mining | PubMed |
1 to 10 of 1,704
See all 1,704 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8838
GET https://conductscience.org/api/genes/v1/8838/patents?page=2